A video, published online in the journal Nature Methods in June, shows a new method for converting electrical activity into fluorescent light. This nascent technology was discovered by 35-year-old Harvard University neuroscientist Adam Cohen, a native New Yorker with two doctorates under his belt. Pharmaceutical companies from Biogen Idec Inc. to GlaxoSmithKline Plc have already lined up to collaborate with Cohen’s biotechnology firm, Q-State Biosciences, hoping to advance drug development. Read more…
